Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bierman

Showing results (211-220 of 253) with videos related to

Pageof 26
Sort By:
Leukemia & Lymphoma|February 26, 1999
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphomaR P Gale, R E Park, R Dubois, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study GroupA A Abou-Elella, D D Weisenburger, J M Vose, et al.
Blood|November 9, 2002
A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survivalChristine P Hans, Dennis D Weisenburger, Julie M Vose, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 18, 2015
Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell TransplantationVijaya Raj Bhatt, Vamshi Balasetti, Jagar A Jasem, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomesKoen van Besien, Jeanette Carreras, Philip J Bierman, et al.
British Journal of Haematology|November 25, 2003
Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's diseaseFrancis J Giles, Julie M Vose, Kim-Anh Do, et al.
Hematological Oncology|October 20, 2011
Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantationKeni Gu, Dennis D Weisenburger, Kai Fu, et al.
Blood|July 13, 2000
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantationM R Bishop, S R Tarantolo, R B Geller, et al.
Leukemia & Lymphoma|April 28, 2000
Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphomaD D Weisenburger, R D Gascoyne, P J Bierman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignanciesZ S Pavletic, M R Bishop, S R Tarantolo, et al.
Pageof 26

Showing results (211-220 of 253) with videos related to

Sort By:
Pageof 26
Leukemia & Lymphoma|February 26, 1999
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphomaR P Gale, R E Park, R Dubois, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study GroupA A Abou-Elella, D D Weisenburger, J M Vose, et al.
Blood|November 9, 2002
A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survivalChristine P Hans, Dennis D Weisenburger, Julie M Vose, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 18, 2015
Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell TransplantationVijaya Raj Bhatt, Vamshi Balasetti, Jagar A Jasem, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomesKoen van Besien, Jeanette Carreras, Philip J Bierman, et al.
British Journal of Haematology|November 25, 2003
Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's diseaseFrancis J Giles, Julie M Vose, Kim-Anh Do, et al.
Hematological Oncology|October 20, 2011
Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantationKeni Gu, Dennis D Weisenburger, Kai Fu, et al.
Blood|July 13, 2000
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantationM R Bishop, S R Tarantolo, R B Geller, et al.
Leukemia & Lymphoma|April 28, 2000
Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphomaD D Weisenburger, R D Gascoyne, P J Bierman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignanciesZ S Pavletic, M R Bishop, S R Tarantolo, et al.
Pageof 26